299 related articles for article (PubMed ID: 27488534)
1. Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk.
Patel YM; Park SL; Han Y; Wilkens LR; Bickeböller H; Rosenberger A; Caporaso N; Landi MT; Brüske I; Risch A; Wei Y; Christiani DC; Brennan P; Houlston R; McKay J; McLaughlin J; Hung R; Murphy S; Stram DO; Amos C; Le Marchand L
Cancer Res; 2016 Oct; 76(19):5768-5776. PubMed ID: 27488534
[TBL] [Abstract][Full Text] [Related]
2. Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
Park SL; Murphy SE; Wilkens LR; Stram DO; Hecht SS; Le Marchand L
PLoS One; 2017; 12(5):e0178435. PubMed ID: 28542511
[TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study.
Yuan JM; Nelson HH; Butler LM; Carmella SG; Wang R; Kuriger-Laber JK; Adams-Haduch J; Hecht SS; Gao YT; Murphy SE
Int J Cancer; 2016 May; 138(9):2161-71. PubMed ID: 26662855
[TBL] [Abstract][Full Text] [Related]
4. CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study.
Yuan JM; Nelson HH; Carmella SG; Wang R; Kuriger-Laber J; Jin A; Adams-Haduch J; Hecht SS; Koh WP; Murphy SE
Carcinogenesis; 2017 Apr; 38(4):411-418. PubMed ID: 28182203
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.
Baurley JW; Edlund CK; Pardamean CI; Conti DV; Krasnow R; Javitz HS; Hops H; Swan GE; Benowitz NL; Bergen AW
Nicotine Tob Res; 2016 Sep; 18(9):1837-1844. PubMed ID: 27113016
[TBL] [Abstract][Full Text] [Related]
6. Nicotine Metabolism and Smoking: Ethnic Differences in the Role of P450 2A6.
Murphy SE
Chem Res Toxicol; 2017 Jan; 30(1):410-419. PubMed ID: 28092945
[TBL] [Abstract][Full Text] [Related]
7. Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity.
Park SL; Tiirikainen MI; Patel YM; Wilkens LR; Stram DO; Le Marchand L; Murphy SE
Carcinogenesis; 2016 Mar; 37(3):269-279. PubMed ID: 26818358
[TBL] [Abstract][Full Text] [Related]
8. CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility.
Du M; Xin J; Zheng R; Yuan Q; Wang Z; Liu H; Liu H; Cai G; Albanes D; Lam S; Tardon A; Chen C; Bojesen SE; Landi MT; Johansson M; Risch A; Bickeböller H; Wichmann HE; Rennert G; Arnold S; Brennan P; Field JK; Shete SS; Le Marchand L; Liu G; Andrew AS; Kiemeney LA; Zienolddiny S; Grankvist K; Johansson M; Caporaso NE; Cox A; Hong YC; Yuan JM; Schabath MB; Aldrich MC; Wang M; Shen H; Chen F; Zhang Z; Hung RJ; Amos CI; Wei Q; Lazarus P; Christiani DC
Cancer Res; 2024 Feb; 84(4):616-625. PubMed ID: 38117513
[TBL] [Abstract][Full Text] [Related]
9. CYP2A6 associates with respiratory disease risk and younger age of diagnosis: a phenome-wide association Mendelian Randomization study.
Giratallah H; Chenoweth MJ; Pouget JG; El-Boraie A; Alsaafin A; Lerman C; Knight J; Tyndale RF
Hum Mol Genet; 2024 Jan; 33(2):198-210. PubMed ID: 37802914
[TBL] [Abstract][Full Text] [Related]
10. Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer.
Tanner JA; Henderson JA; Buchwald D; Howard BV; Nez Henderson P; Tyndale RF
Pharmacogenet Genomics; 2017 May; 27(5):169-178. PubMed ID: 28181923
[TBL] [Abstract][Full Text] [Related]
11. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption.
Bergen AW; Michel M; Nishita D; Krasnow R; Javitz HS; Conneely KN; Lessov-Schlaggar CN; Hops H; Zhu AZ; Baurley JW; McClure JB; Hall SM; Baker TB; Conti DV; Benowitz NL; Lerman C; Tyndale RF; Swan GE;
PLoS One; 2015; 10(7):e0126113. PubMed ID: 26132489
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.
Chenoweth MJ; Ware JJ; Zhu AZX; Cole CB; Cox LS; Nollen N; Ahluwalia JS; Benowitz NL; Schnoll RA; Hawk LW; Cinciripini PM; George TP; Lerman C; Knight J; Tyndale RF;
Addiction; 2018 Mar; 113(3):509-523. PubMed ID: 28921760
[TBL] [Abstract][Full Text] [Related]
13. Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population.
Ezzeldin N; El-Lebedy D; Darwish A; El Bastawisy A; Abd Elaziz SH; Hassan MM; Saad-Hussein A
BMC Cancer; 2018 May; 18(1):525. PubMed ID: 29724170
[TBL] [Abstract][Full Text] [Related]
14. Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism.
Tanner JA; Zhu AZ; Claw KG; Prasad B; Korchina V; Hu J; Doddapaneni H; Muzny DM; Schuetz EG; Lerman C; Thummel KE; Scherer SE; Tyndale RF
Pharmacogenet Genomics; 2018 Jan; 28(1):7-16. PubMed ID: 29232328
[TBL] [Abstract][Full Text] [Related]
15. Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer.
Derby KS; Cuthrell K; Caberto C; Carmella SG; Franke AA; Hecht SS; Murphy SE; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3526-35. PubMed ID: 19029401
[TBL] [Abstract][Full Text] [Related]
16. Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.
Benowitz NL; St Helen G; Dempsey DA; Jacob P; Tyndale RF
Pharmacogenet Genomics; 2016 Jul; 26(7):340-50. PubMed ID: 27035242
[TBL] [Abstract][Full Text] [Related]
17. CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations.
Wassenaar CA; Ye Y; Cai Q; Aldrich MC; Knight J; Spitz MR; Wu X; Blot WJ; Tyndale RF
Carcinogenesis; 2015 Jan; 36(1):99-103. PubMed ID: 25416559
[TBL] [Abstract][Full Text] [Related]
18. A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.
Loukola A; Buchwald J; Gupta R; Palviainen T; Hällfors J; Tikkanen E; Korhonen T; Ollikainen M; Sarin AP; Ripatti S; Lehtimäki T; Raitakari O; Salomaa V; Rose RJ; Tyndale RF; Kaprio J
PLoS Genet; 2015; 11(9):e1005498. PubMed ID: 26407342
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity.
El-Boraie A; Taghavi T; Chenoweth MJ; Fukunaga K; Mushiroda T; Kubo M; Lerman C; Nollen NL; Benowitz NL; Tyndale RF
Addict Biol; 2020 Jan; 25(1):e12741. PubMed ID: 30815984
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme.
Bray MJ; Chen LS; Fox L; Hancock DB; Culverhouse RC; Hartz SM; Johnson EO; Liu M; McKay JD; Saccone NL; Hokanson JE; Vrieze SI; Tyndale RF; Baker TB; Bierut LJ
Genet Epidemiol; 2020 Oct; 44(7):748-758. PubMed ID: 32803792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
